(Q28168089)

English

Limited usefulness of the PFA-100 for the monitoring of ADP receptor antagonists--in vitro experience

scientific article (publication date: 2004)

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Limited usefulness of the PFA-100 for the monitoring of ADP receptor antagonists--in vitro experience (English)

0 references

1

Jacek Golanski

0 references

Cezary Watala

series ordinal

4

object named as

Cezary Watala

0 references

author name string

Justyna Pluta

series ordinal

2

0 references

Janina Baraniak

series ordinal

3

0 references

language of work or name

English

0 references

publication date

January 2004

0 references

published in

Clinical Chemistry and Laboratory Medicine

0 references

volume

42

0 references

issue

1

0 references

page(s)

25-9

0 references

cites work

Rapid assessment of glycoprotein IIb/IIIa blockade with the platelet function analyzer (PFA-100) during percutaneous coronary intervention

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1515%2FCCLM.2004.006

retrieved

21 January 2018

Inhibition of ADP-triggered blood platelet aggregation by diadenosine polyphosphate analogues

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1515%2FCCLM.2004.006

retrieved

21 January 2018

Comparison of in vitro closure time (PFA-100) with whole blood electrical aggregometry and platelet surface antigen expression in healthy volunteers

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1515%2FCCLM.2004.006

retrieved

21 January 2018

PFA-100 and flow cytometry: can they challenge aggregometry to assess antiplatelet agents, other than GPIIbIIIa blockers, in coronary angioplasty?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1515%2FCCLM.2004.006

retrieved

21 January 2018

Platelet-active drugs : the relationships among dose, effectiveness, and side effects

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1515%2FCCLM.2004.006

retrieved

21 January 2018

Rational use of the PFA-100 device for screening of platelet function disorders and von Willebrand disease.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1515%2FCCLM.2004.006

retrieved

21 January 2018

The PFA-100: a potential rapid screening tool for the assessment of platelet dysfunction

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1515%2FCCLM.2004.006

retrieved

21 January 2018

Monitoring of antiplatelet therapy with the PFA-100 in peripheral angioplasty patients

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1515%2FCCLM.2004.006

retrieved

21 January 2018

Clinical application of the PFA-100

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1515%2FCCLM.2004.006

retrieved

21 January 2018

Effect of aspirin treatment in patients with peripheral arterial disease monitored with the platelet function analyzer PFA-100

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1515%2FCCLM.2004.006

retrieved

21 January 2018

Profile and prevalence of aspirin resistance in patients with cardiovascular disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1515%2FCCLM.2004.006

retrieved

21 January 2018

Identifiers

DOI

10.1515/CCLM.2004.006

0 references

PubMed publication ID

15061376

0 references

ResearchGate publication ID

8640861

0 references

(Q28168089)

Limited usefulness of the PFA-100 for the monitoring of ADP receptor antagonists--in vitro experience

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)